GSDMD and colorectal carcinoma: Furthermore, LPS enhances oxaliplatin chemosensitivity to HT29 cells via GSDMD-mediated pyroptosis [138], which provides a reliable therapeutic target against resistance to CRC chemotherapeutic agents.